DE602006014273D1 - Pyrazoloä3 , 4-düazepinderivate als histamin-h3-antagonisten - Google Patents

Pyrazoloä3 , 4-düazepinderivate als histamin-h3-antagonisten

Info

Publication number
DE602006014273D1
DE602006014273D1 DE602006014273T DE602006014273T DE602006014273D1 DE 602006014273 D1 DE602006014273 D1 DE 602006014273D1 DE 602006014273 T DE602006014273 T DE 602006014273T DE 602006014273 T DE602006014273 T DE 602006014273T DE 602006014273 D1 DE602006014273 D1 DE 602006014273D1
Authority
DE
Germany
Prior art keywords
antagonists
derivatives
düazepine
histamine
neurological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602006014273T
Other languages
German (de)
English (en)
Inventor
Mark James Bamford
David Matthew Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DE602006014273D1 publication Critical patent/DE602006014273D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602006014273T 2005-07-06 2006-07-04 Pyrazoloä3 , 4-düazepinderivate als histamin-h3-antagonisten Expired - Lifetime DE602006014273D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0513886.2A GB0513886D0 (en) 2005-07-06 2005-07-06 Novel compounds
PCT/EP2006/006613 WO2007025596A1 (en) 2005-07-06 2006-07-04 Pyrazolo [3 , 4-d] azepine derivatives as histamine h3 antagonists

Publications (1)

Publication Number Publication Date
DE602006014273D1 true DE602006014273D1 (de) 2010-06-24

Family

ID=34856781

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006014273T Expired - Lifetime DE602006014273D1 (de) 2005-07-06 2006-07-04 Pyrazoloä3 , 4-düazepinderivate als histamin-h3-antagonisten

Country Status (27)

Country Link
US (1) US7888347B2 (enExample)
EP (1) EP1899350B1 (enExample)
JP (1) JP5145218B2 (enExample)
KR (1) KR20080037651A (enExample)
CN (1) CN101258154B (enExample)
AT (1) ATE467636T1 (enExample)
AU (1) AU2006286897A1 (enExample)
BR (1) BRPI0612719A2 (enExample)
CA (1) CA2614232A1 (enExample)
CR (1) CR9622A (enExample)
CY (1) CY1110711T1 (enExample)
DE (1) DE602006014273D1 (enExample)
DK (1) DK1899350T3 (enExample)
EA (1) EA013600B1 (enExample)
ES (1) ES2345841T3 (enExample)
GB (1) GB0513886D0 (enExample)
HR (1) HRP20100401T1 (enExample)
IL (1) IL188184A0 (enExample)
MA (1) MA29623B1 (enExample)
MX (1) MX2008000383A (enExample)
NO (1) NO20080563L (enExample)
PL (1) PL1899350T3 (enExample)
PT (1) PT1899350E (enExample)
SI (1) SI1899350T1 (enExample)
UA (1) UA93047C2 (enExample)
WO (1) WO2007025596A1 (enExample)
ZA (1) ZA200710798B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2655604C (en) 2006-06-23 2016-08-09 Abbott Laboratories Cyclopropyl amine derivatives
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
CN101868457B (zh) 2007-09-24 2013-02-13 科门蒂斯公司 作为β-分泌酶抑制剂用于治疗的(3-羟基-4-氨基-丁-2-基)-3-(2-噻唑-2-基-吡咯烷-1-羰基)苯甲酰胺衍生物和相关化合物
US9186353B2 (en) 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
US8853390B2 (en) 2010-09-16 2014-10-07 Abbvie Inc. Processes for preparing 1,2-substituted cyclopropyl derivatives
CN102952139B (zh) * 2011-08-30 2016-08-10 上海药明康德新药开发有限公司 反式-3a-氟吡咯烷[3,4-C]并环化合物及其制备方法
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP2647377A1 (en) 2012-04-06 2013-10-09 Sanofi Use of an h3 receptor antagonist for the treatment of alzheimer's disease
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
US9910887B2 (en) * 2013-04-25 2018-03-06 Facebook, Inc. Variable search query vertical access
JP2019520335A (ja) * 2016-05-25 2019-07-18 アカーナ・セラピューティクス・リミテッドＡｋａｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｌｔｄ． 疾患治療用の縮合二環式化合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9913503A (pt) * 1998-09-09 2002-01-29 Ishihara Sangyo Kaisha Derivados de benzeno-fundidos úteis como herbicidas
EP1173438A1 (en) * 1999-04-16 2002-01-23 Novo Nordisk A/S Substituted imidazoles, their preparation and use
JP2001220390A (ja) 2000-02-09 2001-08-14 Yamanouchi Pharmaceut Co Ltd 縮合ピラゾール誘導体
AU2003229535A1 (en) * 2002-06-06 2003-12-22 Novo Nordisk A/S Substituted hexahydropyrrolo(1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines
US6770597B2 (en) 2002-07-17 2004-08-03 Ishihara Sangyo Kaisha, Ltd. Benzohydrazide derivatives as herbicides and desiccant compositions containing them
MXPA05000945A (es) 2002-07-25 2005-05-16 Pharmacia Italia Spa Biciclo-pirazoles activos como inhibidores de la cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
AU2003256793A1 (en) * 2002-08-20 2004-03-11 Eli Lilly And Company Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
GB0224083D0 (en) 2002-10-16 2002-11-27 Glaxo Group Ltd Novel compounds
GB0224557D0 (en) 2002-10-22 2002-11-27 Glaxo Group Ltd Novel compounds
PT1572215E (pt) 2002-12-20 2009-12-09 Glaxo Group Ltd Derivados de benzo[d]azepina para o tratamento de perturbações neurológicas
SG146683A1 (en) * 2003-09-17 2008-10-30 Janssen Pharmaceutica Nv Fused heterocyclic compounds as serotonin receptor modulators
GB0329214D0 (en) 2003-12-17 2004-01-21 Glaxo Group Ltd Novel compounds
GB0405628D0 (en) 2004-03-12 2004-04-21 Glaxo Group Ltd Novel compounds
GB0408083D0 (en) 2004-04-08 2004-05-12 Glaxo Group Ltd Novel compounds
TW200611701A (en) 2004-06-18 2006-04-16 Glaxo Group Ltd Novel compounds
GB0418267D0 (en) 2004-08-16 2004-09-15 Glaxo Group Ltd Novel compounds
BRPI0518841A2 (pt) 2004-12-07 2008-12-09 Glaxo Group Ltd derivados de indenila e uso destes para o tratamento de transtornos neurolàgicos
KR20070113225A (ko) 2005-03-14 2007-11-28 글락소 그룹 리미티드 히스타민 ｈ３ 수용체에 대해 친화성을 갖는 융합된 티아졸유도체

Also Published As

Publication number Publication date
CN101258154A (zh) 2008-09-03
HRP20100401T1 (hr) 2010-09-30
EP1899350B1 (en) 2010-05-12
WO2007025596A1 (en) 2007-03-08
CR9622A (es) 2008-04-10
BRPI0612719A2 (pt) 2010-11-30
EA200800264A1 (ru) 2008-06-30
UA93047C2 (ru) 2011-01-10
JP2009500366A (ja) 2009-01-08
MX2008000383A (es) 2008-03-07
AU2006286897A1 (en) 2007-03-08
PT1899350E (pt) 2010-07-21
NO20080563L (no) 2008-02-01
MA29623B1 (fr) 2008-07-01
CN101258154B (zh) 2011-01-19
ATE467636T1 (de) 2010-05-15
SI1899350T1 (sl) 2010-09-30
PL1899350T3 (pl) 2010-10-29
KR20080037651A (ko) 2008-04-30
EA013600B1 (ru) 2010-06-30
ES2345841T3 (es) 2010-10-04
EP1899350A1 (en) 2008-03-19
DK1899350T3 (da) 2010-09-06
IL188184A0 (en) 2008-03-20
ZA200710798B (en) 2008-11-26
GB0513886D0 (en) 2005-08-10
JP5145218B2 (ja) 2013-02-13
US20080176832A1 (en) 2008-07-24
US7888347B2 (en) 2011-02-15
CA2614232A1 (en) 2007-03-08
CY1110711T1 (el) 2015-06-10

Similar Documents

Publication Publication Date Title
ATE384050T1 (de) Benzazepinderivate als histamin-h3-antagonisten
CR9622A (es) Derivados de pirazolo[3,4-d]azepina como antagonistas de histamina h3
CY1109069T1 (el) Ενωσεις ιμιδαζοπυριδαζινης
ATE477252T1 (de) Substituierte diazepane als antagonisten an orexinrezeptoren
MY148544A (en) Pyridyl piperidine orexin receptor antagonists
MY161834A (en) Substituted diazepan compounds as orexin receptor antagonists
MX2009005358A (es) Derivados de 5-sulfanilmetil-pirazolo[1,5-a]pirimidin-7-ol como antagonistas de cxcr2.
NO20074977L (no) Fuserte tiazolderivater med affinitet for histamin H3 receptoren
TW200503710A (en) Novel compounds
ATE433966T1 (de) Methylendipiperidinderivate
TW200621716A (en) Novel compounds
TW200514781A (en) Novel compounds
DK1725536T3 (da) Imidazolin-derivater med CB1-antagonistisk aktivitet
TW200611701A (en) Novel compounds
ATE455111T1 (de) Einen azepin-kern enthaltende antagonisten des histaminrezeptors
MX2007006754A (es) Derivados de indenilo y uso de los mismos para el tratamiento de trastornos neurologicos.
ATE481972T1 (de) Chinazolinon-derivate als vanilloid-antagonisten
DK1373218T3 (da) Imidazolylderivater til anvendelse som histamin H3-receptorligander
TW200621255A (en) Novel compounds
UA106617C2 (uk) N-(ГЕТЕРО)АРИЛПІРОЛІДИНОВІ ПОХІДНІ ПІРАЗОЛ-4-ІЛПІРОЛО[2,3-d]ПІРИМІДИНІВ І ПІРОЛ-3-ІЛПІРОЛО[2,3-d]ПІРИМІДИНІВ ЯК ІНГІБІТОРИ ЯНУС-КІНАЗИ

Legal Events

Date Code Title Description
8364 No opposition during term of opposition